Intus Bio
Intus Bio, formerly Shoreline Biome, is a microbiome discovery and understanding company leveraging its proprietary Titan-1™ platform. This platform, which uses a patented assay and AI-driven analysis, surpasses traditional 16S and shotgun metagenomics by providing strain-level data at scale. Their 'sample to solution' approach controls the entire process, from sample preparation to AI analysis, ensuring high accuracy and actionable insights. Titan-1™ is utilized by pharmaceutical and academic organizations for drug development and biomarker discovery, and by commercial lab partners for patient health improvements in areas like gut function and wound management. The company's key differentiator is its ability to identify and track bacterial strains, which are the fundamental units of the microbiome, offering crucial insights for personalized health and diagnostics.
Intus Bio
Intus Bio, formerly Shoreline Biome, is a microbiome discovery and understanding company leveraging its proprietary Titan-1™ platform. This platform, which uses a patented assay and AI-driven analysis, surpasses traditional 16S and shotgun metagenomics by providing strain-level data at scale. Their 'sample to solution' approach controls the entire process, from sample preparation to AI analysis, ensuring high accuracy and actionable insights. Titan-1™ is utilized by pharmaceutical and academic organizations for drug development and biomarker discovery, and by commercial lab partners for patient health improvements in areas like gut function and wound management. The company's key differentiator is its ability to identify and track bacterial strains, which are the fundamental units of the microbiome, offering crucial insights for personalized health and diagnostics.